Insights

Recent Partnerships Maze Therapeutics has recently partnered with Sanofi and launched a player in the Pompe disease therapy market. This presents a sales opportunity for collaboration on innovative treatments.

Funding Growth With significant private financing and cash injections, Maze Therapeutics is poised for future expansion and product development. Engaging with them now could lead to partnership opportunities in funding rounds.

CSO Promotion Eric's promotion to CSO at Maze Therapeutics indicates a focus on research and innovation. Reach out to discuss potential collaborations or to offer supportive services tailored to their research needs.

Revenue Potential Maze Therapeutics falls within the revenue range of $10M - 50M, showcasing their growth potential. Engaging with them early on could lead to establishing long-term partnerships as they grow.

Competitive Landscape Being in the biotechnology research industry, Maze Therapeutics competes with companies like Guardant Health, Editas Medicine, and CRISPR Therapeutics. Understanding their competitive position can guide sales strategies.

Maze Therapeutics Tech Stack

Maze Therapeutics uses 8 technology products and services including Anaplan, NetSuite, Microsoft Word, and more. Explore Maze Therapeutics's tech stack below.

  • Anaplan
    Corporate Performance Management
  • NetSuite
    E-commerce
  • Microsoft Word
    Editors
  • OWL Carousel
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • DocuSign
    Miscellaneous
  • PHP
    Programming Languages
  • Microsoft Teams
    Team Collaboration

Media & News

Maze Therapeutics's Email Address Formats

Maze Therapeutics uses at least 1 format(s):
Maze Therapeutics Email FormatsExamplePercentage
FLast@mazetx.comJDoe@mazetx.com
94%
Last@mazetx.comDoe@mazetx.com
4%
FMiddleLast@mazetx.comJMichaelDoe@mazetx.com
2%

Frequently Asked Questions

Where is Maze Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Maze Therapeutics's main headquarters is located at 171 Oyster Point Blvd Suite 300 South San Francisco, California 94080 US. The company has employees across 3 continents, including North AmericaEuropeAfrica.

What is Maze Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Maze Therapeutics's official website is mazetx.com and has social profiles on LinkedIn.

How much revenue does Maze Therapeutics generate?

Minus sign iconPlus sign icon
As of June 2024, Maze Therapeutics's annual revenue reached $15M.

What is Maze Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Maze Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Maze Therapeutics have currently?

Minus sign iconPlus sign icon
As of June 2024, Maze Therapeutics has approximately 119 employees across 3 continents, including North AmericaEuropeAfrica. Key team members include Chief Executive Officer: C. H.Chief Executive Officer: J. C.Chief Medical Officer: S. N.. Explore Maze Therapeutics's employee directory with LeadIQ.

What industry does Maze Therapeutics belong to?

Minus sign iconPlus sign icon
Maze Therapeutics operates in the Biotechnology Research industry.

What technology does Maze Therapeutics use?

Minus sign iconPlus sign icon
Maze Therapeutics's tech stack includes AnaplanNetSuiteMicrosoft WordOWL CarouselMicrosoftDocuSignPHPMicrosoft Teams.

What is Maze Therapeutics's email format?

Minus sign iconPlus sign icon
Maze Therapeutics's email format typically follows the pattern of . Find more Maze Therapeutics email formats with LeadIQ.

How much funding has Maze Therapeutics raised to date?

Minus sign iconPlus sign icon
As of June 2024, Maze Therapeutics has raised $190M in funding. The last funding round occurred on Jan 10, 2022.

When was Maze Therapeutics founded?

Minus sign iconPlus sign icon
Maze Therapeutics was founded in 2018.
Maze Therapeutics

Maze Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have enabled us to decode the mysteries of genetic modifiers in a range of severe diseases, which we aim to turn into medicines that mimic protective mutations. We have assembled a world-class team that we need to realize this vision, including creative scientific pioneers in genetics, experienced company builders, and biotech industry leaders.

Section iconCompany Overview

Headquarters
171 Oyster Point Blvd Suite 300 South San Francisco, California 94080 US
Website
mazetx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $190M

    Maze Therapeutics has raised a total of $190M of funding over 3 rounds. Their latest funding round was raised on Jan 10, 2022.

  • $10M$50M

    Maze Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $190M

    Maze Therapeutics has raised a total of $190M of funding over 3 rounds. Their latest funding round was raised on Jan 10, 2022.

  • $10M$50M

    Maze Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.